Similar articles for PMID: 19541816

Year	Number of Results
2000	1
2001	1
2002	2
2003	1
2004	4
2005	6
2006	1
2007	3
2008	6
2009	15
2010	10
2011	16
2012	7
2013	7
2014	14
2015	9
2016	7
2017	7
2018	4
2019	4
2020	1
2021	0

1

Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H; ALERT study group. Abedini S, et al. Clin J Am Soc Nephrol. 2009 Jul;4(7):1246-54. doi: 10.2215/CJN.00930209. Epub 2009 Jun 18. Clin J Am Soc Nephrol. 2009. PMID: 19541816 Free PMC article.

2

Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.

Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H. Svensson M, et al. Nephrol Dial Transplant. 2012 Jun;27(6):2571-5. doi: 10.1093/ndt/gfr694. Epub 2011 Dec 15. Nephrol Dial Transplant. 2012. PMID: 22172725 Clinical Trial.

3

Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.

Hung SC, Hsu TW, Lin YP, Tarng DC. Hung SC, et al. Clin J Am Soc Nephrol. 2012 Aug;7(8):1257-65. doi: 10.2215/CJN.08410811. Epub 2012 May 24. Clin J Am Soc Nephrol. 2012. PMID: 22626963 Free PMC article.

4

Inflammation-associated graft loss in renal transplant recipients.

Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H. Dahle DO, et al. Nephrol Dial Transplant. 2011 Nov;26(11):3756-61. doi: 10.1093/ndt/gfr163. Epub 2011 Apr 21. Nephrol Dial Transplant. 2011. PMID: 21511816 Clinical Trial.

5

Inflammatory Markers and Outcomes in Kidney Transplant Recipients.

Molnar MZ, Nagy K, Remport A, Tapolyai MB, Fülöp T, Kamal F, Kovesdy CP, Mucsi I, Mathe Z. Molnar MZ, et al. Transplantation. 2017 Sep;101(9):2152-2164. doi: 10.1097/TP.0000000000001548. Transplantation. 2017. PMID: 27798514

6

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

Sun J, Axelsson J, Machowska A, Heimbürger O, Bárány P, Lindholm B, Lindström K, Stenvinkel P, Qureshi AR. Sun J, et al. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1163-72. doi: 10.2215/CJN.10441015. Epub 2016 Jun 8. Clin J Am Soc Nephrol. 2016. PMID: 27281698 Free PMC article.

7

Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.

Tripepi G, Mattace Raso F, Sijbrands E, Seck MS, Maas R, Boger R, Witteman J, Rapisarda F, Malatino L, Mallamaci F, Zoccali C. Tripepi G, et al. Clin J Am Soc Nephrol. 2011 Jul;6(7):1714-21. doi: 10.2215/CJN.11291210. Epub 2011 Jun 3. Clin J Am Soc Nephrol. 2011. PMID: 21642364 Free article.

8

Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H; Assessment of Lescol in Renal Transplantation Study Group. Norby GE, et al. Arthritis Rheum. 2009 Apr;60(4):1060-4. doi: 10.1002/art.24379. Arthritis Rheum. 2009. PMID: 19333947 Free article. Clinical Trial.

9

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.

Baia LC, Humalda JK, Vervloet MG, Navis G, Bakker SJ, de Borst MH; NIGRAM Consortium. Baia LC, et al. Clin J Am Soc Nephrol. 2013 Nov;8(11):1968-78. doi: 10.2215/CJN.01880213. Epub 2013 Aug 8. Clin J Am Soc Nephrol. 2013. PMID: 23929933 Free PMC article.

10

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.

Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, Jardine A, Holdaas H. Abedini S, et al. Kidney Int. 2010 Jan;77(1):44-50. doi: 10.1038/ki.2009.382. Kidney Int. 2010. PMID: 19847152 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed